-
Insights From a French Postmarketing Authorization Early Access (MA EA) Mechanism: Projecting Clinical and Economic Benefits of Neoadjuvant Nivolumab–Platinum-Based Chemotherapy (PDC) in Resectable Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Conceptualizing an Economic Model Structure for Parkinson's Disease
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Transcatheter Valve Replacement Using Valves With RESILIA Tissue for the Treatment of Aortic Stenosis in South Korea
Sep 9, 2025, 16:22 PM -
Sex Differences in Autoimmune Multimorbidity Across 11 Autoimmune Disorders in the Real-World Setting in Germany
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Economic Outcomes in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) in the US: A Real-World Claims Database Analysis
Sep 9, 2025, 16:22 PM -
Identifying Methods Used Within Early Value Assessments for NICE: Results of a Scoping Review
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review and Network Meta-Analysis of Once-Weekly Icosema With Daily Fixed-Dose Combinations of Basal Insulin and GLP-1 RA in Patients With Type 2 Diabetes After 52 Weeks of Treatment
Sep 9, 2025, 16:22 PM -
We Hear What You Are Saying: The Development and Design of the Qualitative Interview Feedback Survey (QIFS) for Use in Qualitative Patient-Centered Outcomes Research Studies
Sep 9, 2025, 16:22 PM -
The Association Between Generalized Anxiety Disorder Symptom Severity and Comorbid Health Conditions Among the US General Adult Population
Sep 9, 2025, 16:22 PM -
Advancing Patient Involvement in Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Feasibility of Indication-Specific Pricing for Life Cycle Management of an Innovative Rare Disease Product
Sep 9, 2025, 16:22 PM -
Patient Blood Management Efficiency in Patients Subject to Orthopedic and Oncologic Elective Surgery
Sep 9, 2025, 16:22 PM -
Comparing Alternative Extrapolation Methods Using Standard Partitioned Survival Model Functionality in the Presence of Converging Survival Data: A Case Study in Renal Cell Carcinoma
Sep 9, 2025, 16:22 PM -
The Landscape of Antibiotic Development and Regulation in the United States and Europe, Alongside Evolving Industry Incentive Strategies
Sep 9, 2025, 16:22 PM -
German HTA Outcomes for Rare Disease Drugs When Orphan Designation Does Not Legally Determine Added Benefit
Sep 9, 2025, 16:22 PM -
The 90-Day Ambition: Historical Analysis of 200 NICE Appraisals to Assess Proportion-Achieving Final Guidance Within 90 Days of MHRA Approval
Sep 9, 2025, 16:22 PM -
Exploring Perspectives on Adult Pneumococcal Vaccination: A Qualitative Preference Study of Health Care Providers (HCPs) and Health Care Consumers (HCCs) in the United Kingdom, Italy, and Greece
Sep 9, 2025, 16:22 PM -
Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy Patients in the Brazilian Public Health System: A Real-World Study
Sep 9, 2025, 16:22 PM -
Public Health Impact of 25 Years of Pneumococcal Conjugate Vaccination in Children 5 Years Old: A Modeling Analysis
Sep 9, 2025, 16:22 PM -
Budget Impact of a PreTRM-Guided Preventive Bundle for Preterm Birth in Low-Risk Pregnancies: A Microsimulation Study Using PRIME Trial Data
Sep 9, 2025, 16:22 PM
